http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7361e3d7aca87bbf1cc53ed8a22a4f12
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Melino |
| name | Gerry Melino |
| given-name | Gerry |
| organization-name | Biochemistry Laboratory, Instituto Dermopatico Dell'Immacolata, Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata,” 00133 Rome, Italy; Toxicology Unit, Medical Research Council, Leicester University, Leicester LE1 9HN, United Kingdom IDI-IRCCS Unit, Departments of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” Rome Medical Research Council Toxicology Unit Leicester UK; Department of Experimental Medicine and Surgery University of Rome “Tor Vergata” Rome Italy Medical Research Council, Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK; Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy Department of Experimental Medicine, TOR, University of Rome “Tor Vergata”, Rome 00133, Italy; MRC-Toxicology Unit, University of Cambridge, Cambridge, UK Department of Experimental Medicine Torvergata Oncoscience Research Centre of Excellence, TOR University of Rome Tor Vergata Italy 1Department of Experimental Medicine, TOR, University of Rome ‘Tor Vergata’, Rome, Italy Department of Experimental Medicine University of Rome Tor Vergata TOR Rome Italy Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Leicester LE1 9HN, UK; Biochemistry Laboratory, IDI-IRCCS, and Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata”, 00133 Rome, Italy Laboratory of Molecular Pharmacology, Saint-Petersburg Technological Institute, 26 Moskovsky Prospect, St. Petersburg, Russia; MRC Toxicology Unit, Leicester, UK 4Medical Research Council, Toxicology Unit, Leicester University, Leicester, United Kingdom Istituto Dermopatico dell‘Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Laboratory of Biochemistry, Department of Experimental Medicine and Biochemical Sciences, and University of Rome “Tor Vergata,” 00133 Rome, Italy;; Association Cell Death and Differentiation c/o Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy;; Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom;; Department for Molecular Biomedical Research, VIB, B-9052 Ghent, Belgium; and; Department of Biomedical Molecular Biology, Ghent University, B-9000 Ghent, Belgium Medical Research Council Toxicology Unit, Leicester LE1 9HN, UK; University of Rome Tor Vergata, 00133-Rome, Italy Medical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom;; Department of Experimental Medicine and Surgery, Biochemistry Istituto Dermopatico dell'Immacolata Laboratory, University of Rome Tor Vergata, 00133 Rome, Italy Department of Experimental Medicine and Surgery; University of Rome Tor Vergata; Rome 00133 Italy; Medical Research Council; Toxicology Unit; Leicester University; Leicester LE1 9HN; UK Medical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom;; Department of Experimental Medicine and Surgery, Biochemistry Istituto Dermopatico dell’Immacolata Laboratory, University of Rome Tor Vergata, 00133 Rome, Italy Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Lancaster Road, Leicester, UK; Biochemistry Laboratory IDI-IRCCS, c/o/ Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata”, Via Montpellier 1, Rome, Italy; Institute of Cellular Biology and Neurobiology, CNR, Rome, Italy Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy MRC Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom; and Department of Experimental Medicine TOR University of Rome“Tor Vergata” Rome 50‐00133 Italy Biochemistry Laboratory, IDI-IRCCS, c/o Tor Vergata University, Via Montpellier, 1, 00133 Roma, Italy; MRC Toxicology Unit, Hodgkin Building, Leicester University, Lancaster Road,Leicester LE1 9HN, UK *Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata–Istituto di Ricovero e Cura a Carattere Scientifico, University of Rome “Tor Vergata,” 00133 Rome, Italy;; Toxicology Unit, Medical Research Council, University of Leicester, Leicester LE1 9HN, United Kingdom; Department of Biochemistry and Molecular Biology, Research Center for Molecular Medicine, Department of Pathology, Third Department of Medicine, Institute of Immunology, University of Debrecen, Debrecen H-4012, Hungary; National Institute of Infectious Diseases “La Spallanzani,” 00149 Rome, Italy; Departments of Biology and Experimental and Biochemical Science, University of Tor Vergata, 00133 Rome, Italy; Matrix Biology and Tissue Repair Research Unit, Dental School, University of Wales... Medical Research Council; Toxicology Unit; Leicester University; Leicester, UK; Molecular Pharmacology Laboratory; Saint-Petersburg Institute of Technology; Saint-Petersburg, Russia; Department of Experimental Medicine and Surgery; University of Rome “Tor Vergata”; Rome, Italy; Biochemistry Laboratory IDI-IRCC; Rome, Italy Department of Experimental Medicine, University of Rome “Tor Vergata”, 00133 Rome, Italy. Department of Experimental Medicine TOR University of Rome “Tor Vergata” Italy; Medical Research Council, Toxicology Unit University of Cambridge UK Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata,” Rome, Italy.; Medical Research Council, Toxicology Unit, Leicester University, Leicester, United Kingdom. 2 Department of Experimental Medicine and Biochemical Sciences University of Rome Tor Vergata, Rome, Italy Department of Experimental Medicine and TOR, University of Rome “Tor Vergata”, Rome, Italy; MRC-Toxicology Unit, University of Cambridge, Cambridge, UK Medical Research Council, Toxicology Unit, LE1 9HN, Leicester, UK. gm89@le.ac.uk Medical Research Council Toxicology Unit, Leicester University, Leicester, United Kingdom; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy Biochemistry Department of Experimental Medicine and Surgery University of Rome Tor Vergata Rome Italy Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK; Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome 00133, Italy; Biochemistry Laboratory IDI-IRCC, University of Rome “Tor Vergata”, Rome 00133, Italy 3IDI-IRCCS Biochemistry Lab, Department of Experimental Medicine, University of Rome “Tor Vergata,” 00139 Rome, Italy; 5Toxicology Unit, Medical Research Council, University of Leicester, Leicester LE1 9HN, England, UK Molecular Pharmacology Laboratory, Saint-Petersburg Institute of Technology, Saint-Petersburg, Russia; MRC Toxicology Unit, University of Leicester, Leicester, UK; Faculty of Medicine, University of Rome “Tor Vergata”, Rome, Italy IDI-IRCCS, Biochemistry Laboratoryc/o Department of Experimental MedicineUniversity of Rome-«Tor Vergata» RomeItaly Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK; Biochemistry Laboratory, IDI-IRCCS, University of Rome Tor Vergata, Rome 00133, Italy; Molecular Pharmacology Laboratory, Technological University, St-Petersburg, Russia Biochemistry, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy Toxicology Unit, Medical Research Council, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, United Kingdom *Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom;; Biochemistry Laboratory, IDI-IRCCS, University of Rome “Tor Vergata,” 00133 Rome, Italy Medical Research Council, Toxicology Unit, Leicester LE1 9HN, UK; Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, 00133 Rome, Italy; Biochemistry Laboratory IDI-IRCC, c/o Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, 00133 Rome, Italy Department of Experimental Medicine and Surgery, University of “Tor Vergata”, 00133 Rome, Italy;; Toxicology Unit, Medical Research Council, Leicester LE1 9HN, United Kingdom; Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom;; Biochemistry Laboratory, Istituto Dermopatico dell’Immacolata/Istituto di Ricovero e Cura a Carattere Scientifico, University of Rome “Tor Vergata,” 00133 Rome, Italy Toxicology Unit, Medical Research Council, Leicester LE1 9HN, United Kingdom;; Biochemistry Laboratory, Istituto Dermopatico dell’Immacolata–Istituto di Ricovero e Cura a Carattere Scientifico and University of Rome Tor Vergata, 00133 Rome, Italy Department of Experimental MedicineUniversity of Rome Tor VergataRomeItaly Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK; Biochemistry Laboratory, IDI-IRCCS, and University of Rome “Tor Vergata”, 00133 Rome, Italy IDI-IRCCS Biochemistry Lab, Department of Experimental Medicine, University Tor Vergata, Rome, Italy From the Department of Internal Medicine (R.M., V.C., M.C., R.L., M.F.), Department of Surgery (E.M., A.I.), IDI-IRCCS Biochemistry Laboratory, c/o Department of Experimental Medicine (A.T., G.M.), and Department of Biopathology and Imaging (F.A., G.N.), University of Rome Tor Vergata, Rome, Italy; and Medical Research Council (M.V.-N., G.M.), Toxicology Unit, University of Leicester, Leicester, United Kingdom. Medical Research Council, Toxicology Unit, Leicester, United Kingdom; Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom;; Biochemistry Laboratory, IDI-IRCCS, University of Rome “Tor Vergata”, 00133 Rome, Italy; and Biochemistry Laboratory IDI-IRCCS and University of Rome “Tor Vergata,” Rome, Italy; MRC Toxicology Unit, Leicester, United Kingdom Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom;; Department of Molecular Biomedical Research, Flanders Institute for Biotechnology, B-9052 Ghent, Belgium;; Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico and University of Rome “Tor Vergata,” 00133 Rome, Italy; Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK; Biochemistry Laboratory, IDI-IRCCS, c/o University of Rome ‘Tor Vergata’, 00133 Rome, Italy From the *Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata-IRCCS, Department of Experimental Medicine, University of Rome “Tor Vergata,” 00133 Rome, Italy; and the ‡Laboratory of Gene Expression, Fondazione Andrea Cesalpino, University of Rome “La Sapienza,” 00161 Rome, Italy Department of Experimental Medicine and Biochemical Sciences 1 , 2 , and 3; Dermopathic Institute of the Immaculate 1 , 2 , and 3; Department of Biopathology and Image Diagnostics, University of Rome Tor Vergata, 00173 Rome, Italy 1 , 2 , and 3; Department of Experimental Medicine and Biochemical Sciences 1 , 2 , and 3; Dermopathic Institute of the Immaculate 1 , 2 , and 3; Department of Biopathology and Image Diagnostics, University of Rome Tor Vergata, 00173 Rome, Italy 1 , 2 , and 3; Toxicology Unit, Medical Research Council, Leicester University, LE1 7HB Leicester, England, UK 4; Department for Molecular Biomedical Research, Flanders Institute for Biotechnology, Gent-Zwijnaarde 9052, Belgium 5; Department of Biomedical Molecular Biology, Ghent University, Gent-Zwijnaarde 9052, Belgium 6 *Fondazione S. Lucia, Roma, Italy and Medical Research Council, Toxicology Unit, Leicester, U.K. Biochemistry Laboratory, Istituto Dermopatico dell’Immacolata–Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), c/o Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy.; Toxicology Unit, Medical Research Council, Leicester University, Hodgkin Building, P.O. Box 138, Leicester LE1 9HN, UK. Department of Experimental Medicine, Tor Vergata Oncoscience Research (TOR), University of Rome Tor Vergata, 00133 Rome, Italy Biochemistry Laboratory, Istituto Dermopatico Immacolata (IDI-IRCCS), Rome, Italy; Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy MRC Toxicology Unit, Leicester, UK Department of Experimental Medicine and Biochemical Sciences, Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico, Università degli Studi di Roma “Tor Vergata,” 00133 Rome, Italy; and; Medical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom Department of Experimental Medicine, TOR University of Rome "Tor Vergata", Rome 00133, Italy; Medical Research Council, Toxicology Unit, University of Cambridge, Leicester LE1 9HN, UK Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy; Toxicology Unit, Medical Research Council, Leicester, U.K. Biochemistry Laboratory IDI-IRCCS,University of Rome ‘Tor Vergata’, Rome 00133, Italy; and; MRC Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom Medical Research Council Toxicology Unit, Leicester, UK; Department of Experimental Medicine & Surgery, University of Rome “Tor Vergata”, Rome, Italy University of “Tor Vergata”, Department of Experimental Medicine and Surgery, 00133 Rome, Italy; IDI-IRCCS, Laboratory of Biochemistry, c/o Department of Experimental Medicine and Surgery, University of “Tor Vergata”, 00133 Rome, Italy; Association Cell Death & Differentiation, c/o Department of Experimental Medicine and Surgery, University of “Tor Vergata”, 00133 Rome, Italy; Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Leicester LE1 9HN, UK Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", 00133 Rome, Italy; Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Lancaster Road, P.O. Box 138, Leicester LE1 9HN, UK Toxicology Unit, Medical Research Council, Leicester University, Leicester LE1 9HN, United Kingdom;; Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico and University of Rome “Tor Vergata”, 00133 Rome, Italy; MRC Toxicology Unit, University of Leicester, Leicester LE1 9HN, UK. *Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom;; Biochemistry Laboratory, Istituto Dermopatico dell’Immacolata–Istituto di Ricovero e Cura a Carattere Scientifico, Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” 00133 Rome, Italy Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Via Montpellier, Rome, Italy; Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Leicester, United Kingdom Kimmel Cancer Institute, Thomas Jefferson University, 233 South 10th Street, Philadelphia, PA 19107; AxCell Biosciences Corporation, 826 Newtown-Yardley Road, Newtown, PA 18940; and Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata–Istituto di Ricovero e Cura a Carattere Scientifico, Department of Experimental Medicine, University of Rome “Tor Vergata,” 00133 Rome, Italy Biochemistry IDI-IRCCS Lab, c/o University of Rome “Tor Vergata,” 00133 Rome, Italy; and; Toxicology Unit, Medical Research Council Leicester, Leicester LE1 9HN. United Kingdom 2Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome, Italy.; 3Medical Research Council, Toxicology Unit, Department of Pathology, Cambridge University, Cambridge, United Kingdom. St. Petersburg State Technological Institute (Technical University), St. Petersburng, Russia; University of Rome Tor Vergata, Roma, Italy MRC Toxicology Unit, University of Cambridge, Rome, UK; Department of Experimental Medicine and Surgery, IDI-IRCCS, University of Rome Tor Vergata, Rome, Italy 2 Department of Experimental Medicine and Biochemical Sciences University of Rome ‘Tor Vergata’, Rome, Italy University of Rome “Tor Vergata,” Department of Experimental Medicine and Surgery, 00133, Rome, Italy Department of Experimental Medicine TOR University of Rome Tor Vergata Rome 00133 Italy MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, United Kingdom; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome 00133, Italy; Institute of Cytology Russian Academy of Sciences, Saint-Petersburg, 194064, Russia Medical Research Council (MRC); Toxicology Unit; Leicester University; Leicester, UK; Laboratorio di Biochimica IDI-IRCC c/o Dipartimento di Biochimica e Chirugia; University of Rome “Tor Vergata”; Rome, Italy Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Rome 00133, Italy. Biochemistry Laboratory, IDI-IRCCS, c/o Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” Rome, Italy; Toxicology Unit, Medical Research Council, Leicester University, Leicester Medical research Council, Toxicology Unit, Leicester University, Leicester, UK; Biochemistry IDI-IRCCS Laboratory, Department of Experimental Medicine and Surgery, University of Rom ‘Tor Vergata’, Rome, Italy Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK; Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy Biochemistry Laboratory, IDI-IRCCS, c/o University of Rome `Tor Vergata', 00133 Rome, Italy; Fondazione S. Lucia, via Ardeatina, 00179 Rome, Italy; Medical Research Council, Toxicology Unit, Leicester University, Leicester, LE1 9HN, UK Laboratory of Apoptosis and Cancer, Medical Research Council Toxicology Unit, University of Leicester, Hodgkin Building, PO Box 138, Lancaster Road, LE1 9HN, Leicester, United Kingdom;; Department of Biology, Instituto Dermopatico dell’Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico, University of Rome Tor Vergata, 00133 Rome, Italy; MRC Toxicology Unit, University of Cambridge, Leicester LE1 7HB, United Kingdom; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy Department of Experimental Medicine and Surgery University of ‘Tor Vergata’ Rome Italy; MRC Toxicology Unit Leicester UK Department of Experimental Medicine, TOR, University of Rome “Tor Vergata”, Rome, Italy 6 Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133 Rome, Italy Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy; Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Lancaster Road, P.O. Box 138, Leicester LE1 9HN, U.K. Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", 00133 Rome, Italy MRC Toxicology Unit, Leicester, LE1 9HN, UK; Molecular Pharmacology Laboratory, Saint-Petersburg Institute of Technology, Saint-Petersburg, 190013, Russia Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK; Department of Experimental Medicine and Surgery, Biochemistry IDI-IRCCS Laboratory, University of Rom ‘Tor Vergata’, Rome, Italy Medical Research Council Toxicology Unit, Leicester LE1 9HN, UK; Molecular Pharmacology Laboratory, Technological University, St-Petersburg, Russia; Department of Experimental Medicine & Surgery, University of Rome “Tor Vergata”, 00133 Rome, Italy Molecular Pharmacology Laboratory, Techological University, St-Petersburg, Russia; MRC Toxicology Unit, Leicester University, Lancaster Road, Leicester, UK Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, 00133 Rome, Italy; Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, Leicester LE1 9HN, UK §Istituto Dermopatico dell’Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico Biochemistry Laboratory, Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata,” Rome, Italy; Biochemistry Laboratory Istituto Dermopatico Dell'Immacolata, c/o Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata,” 00133 Rome, Italy;; Toxicology Unit, Medical Research Council, Leicester University, Leicester LE1 9HN, United Kingdom MRC Toxicology Unit, University of Leicester, Leicester LE1 9HN, England, UK 5 Medical Research Council, Toxicology Unit, Leicester, UK; Biochemistry Laboratory, IDI-IRCCS, c/o Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy Biochemistry Laboratory, Istituto Dermopatico dell’Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico, Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata,” 00133 Rome, Italy;; Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom; and Department of Experimental Medicine and Biochemical Sciences University of Rome Tor Vergata Rome Italy Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester LE1 9HN, UK; Biochemistry IDI-IRCCS Laboratory, Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy Authors' Affiliations: 1The Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel; and 2Leicester University, MRC-Toxicology Unit, Leicester, UK Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, United Kingdom;; Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata/Istituto Di Ricovero e Cura a Carattere Scientifico, University of Rome “Tor Vergata,” 00133 Rome, Italy; adm MRC Toxicology Unit , Leicester , UK. bti University of Rome "Tor Vergata" , Department of Surgery and Experimental Medicine , Rome , Italy. IDI-IRCCS Biochemistry Lab c/o the Department of Experimental Medicine, University of Rome “Tor Vergata,” Rome |
Incoming Links
Total number of triples: 492.